nach oben

Clinical and Experimental Nephrology

Erschienen in:

01.06.2008 | Review Article

Characteristics of the clinical practice patterns of hemodialysis in Japan in consideration of DOPPS and the NKF/DOQI guidelines

verfasst von: Satoru Kuriyama

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Excerpt

Dialysis was regarded as an exploratory attempt to sustain a patient’s life until the 1960s in many countries. Indeed, the prognosis of patients with terminal-stage chronic renal failure (CRF) was poor and catastrophic at that time [1]. However, owing to improvements in medical technology and medicine for dialysis, advances in the management of coronary artery disease and critical care medicine as well as the concept of initiating renal replacement therapy earlier, dialysis has started to provide greater benefits than before as a life-saving chronic renal replacement therapy for millions of people worldwide. These days, dialysis is an efficient and reliable therapeutic measure to maintain a patient’s life for over a decade if the patient’s condition allows. …

Ghavamian M, Gutch CF, Kopp KF, Kolff WJ. The sad truth about hemodialysis in diabetic nephropathy. JAMA. 1972;222:1386–9.PubMedCrossRef

Locatelli F, Pisoni RL, Combe C, Bommer J, Andreucci VE, Piera L, Greenwood R, Feldman HI, Port FK, Held PJ. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004;19:121–32.PubMedCrossRef

Young EW, Satayathum S, McCullough K, Bommer J, Andreucci V, Goodkin DA, Mapes DL, Dykstra DM, Port FK, Held PJ. European facility practice patterns related to mineral metabolism in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2002;17:23–30.

Saran R, Pisoni RL, Weitzel WF. Epidemiology of vascular access for hemodialysis and related practice patterns. Contrib Nephrol. 2004;142:14–28.PubMed

Rayner HC, Pisoni RL, Gillespie BM, Goodkin DA, Akiba T, Akizawa T, Saito A, Young EW, Port FK. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2003;63:323–30.PubMedCrossRef

Young EW, Dykstra DM, Goodkin DA, Mapes DL, Wolfe RA, Held PJ. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2002;61:2266–71.PubMedCrossRef

Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, Bommer J, Cruz JM, Kerr PG, Mendelssohn DC, Held JP, Port FK. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44(7):94–111.PubMedCrossRef

Pisoni RL, Young EW, Combe C, Leavey SF, Geenwood RN, Hecking E, Canaud BJ, Locatelli F. Higher catheter use within facilities is associated with increased mortality and hospitalization: result from DOPPS. J Am Soc Nephrol. 2001;12:299 A.

Akizawa T, Young EW, Maroni BJ, Andreucci VE, Kurokawa K, Marumo F, Held PJ. Nutritional status across three continents: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2000;11:254A.

10.

Mapes DL, Lopes AA, Satayathum S, McCullough KP, Goodkin DA, Locatelli F, Fukuhara S, Young EW, Kurokawa K, Saito A, Bommer J, Wolfe RA, Held PJ, Port FK. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2003;64:339–49.PubMedCrossRef

11.

Fukuhara S, Lopes AA, Bragg-Gresham JL, Kurokawa K, Mapes DL, Akizawa T, Bommer J, Canaud BJ, Port FK, Held PJ. Health-related quality of life among dialysis patients on three continents: the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2003;64:1903–10.PubMedCrossRef

12.

Pifer TB, Satayathum S, Dykstra DM, Mapes DL, Goodkin DA, Canaud B, Bommer J, Kurokawa K, Held PJ, Pisoni RL, Wolfe RA, Young EW. Hemodialysis staffing and patient outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2002;13:425A.

13.

Saran R, Bragg-Gresham JL, Rayner HC, Goodkin DA, Keen ML, Van Dijk PC, Kurokawa K, Piera L, Saito A, Fukuhara S, Young EW, Held PJ, Port FK. Non-adherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int. 2003;64:254–62.PubMedCrossRef

14.

Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Aizawa T, Kirokawa K, Bommer J, Piera L, Port FK. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2005;67(3):1179–87.PubMedCrossRef

15.

Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, Saito A, La-Brecque J, Port FK, Young EW. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2003;63:2222–9.PubMedCrossRef

16.

Fissel RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW. Pattern of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004;65(6):2335–42.CrossRef

17.

Saran R, Dykstra DM, Wolfe RA, Gillespie B, Held PJ, Young EW. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2002;40:1255–63.PubMedCrossRef

18.

Vassalottie JA, Falk A, Cohl ED, Uribarri J, Teodorescue V. Obese and non-obese hemodialysis patients have a similar prevalence of functioning arteriovenous fistula using pre-operative vein mapping. Clin Nephrol. 2002;58:211–4.

19.

Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, Piera L, Held P, Gillespie B, Port FK. Dialysis Outcomes and Practice Patterns Study (DOPPS). Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 2002;62:199–207.PubMedCrossRef

20.

Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizeman V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in DOPPS. Kidney Int. 2006;69:1222–8.PubMedCrossRef

21.

Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, Saito A, Rayner HC, Kurokawa K, Port FK, Held PJ, Young EW. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2003;14:3270–7.PubMedCrossRef

22.

Goodkin DA, Dickinson DM, Rasmussen CS, Kurokawa K, Akiba T, Held PJ. Components of hemodialysis dose: result from 7 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol. 2000;11:320A.

23.

Saran R, Canaud BJ, Depner TA, Keen ML, McCullough KP, Marshal MR, Port FK. Dose of dialysis: key lessons from major observational studies and clinical trials. Am J Kidney Dis. 2004;11(44):s47–53.CrossRef

24.

Pifer TB, McCullough KP, Port FK, Goodkin DA, Maroni BJ, Held PJ, Young EW. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int. 2002;62:2238–45.PubMedCrossRef

25.

Leavey SF, McCullough KP, Hecking E, Goodkin DA, Port FK, Young EW. Body mass index and mortality in ‘healthier’ as compared with ‘sicker’ haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2001;16:2386–94.PubMedCrossRef

26.

Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK. Body size dose of hemodialysis, mortality. Results from USRDS Special Study. Am J Kidney Dis. 2000;35:80–8.PubMedCrossRef

27.

Port FK, Ashby VB, Dhingra RK, Roys E, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol. 2002;13:1061–6.PubMed

28.

Port FK, Wolfe RA, Hulbert-Shearon TE, Daugiedas JT, Agodoa LYC, Jones C, Orzol SM, Held PJ. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the USRDS Dialysis Morbidity and Mortality Study. Am J Kidney Dis. 2001;37:276–86.PubMedCrossRef

29.

Port FK, Rasmussen CS, Leavy SF, Wolfe RA, Kurokawa K, Akizawa T, Saito A, Piera L, Held PJ, Young EW. Association of blood flow rate and treatment time with mortality risk in HD patients across three continents. J Am Soc Nephrol. 2001;12:343A–4A.

30.

Port FK, Eknoyan G. The dialysis outcomes and practice patterns study (DOPPS) and the kidney disease outcomes quality initiatives (K/DOQI): a cooperative initiative to improve outcomes for hemodialysis patients worldwide. Am J Kidney Dis. 2004;44(5 suppl 2):s1–6.CrossRef

31.

NKF. DOQI clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis. 1997;30:S15–66.CrossRef

32.

National Kidney Foundation. DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis. 1997;30(suppl 3):S192–240.

33.

National Kidney Foundation. K/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000. Am J Kidney Dis. 2001;37(suppl 1):S182–238.

34.

National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2005;45(4 suppl 3):S1–138.

35.

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–266.

36.

National Kidney Foundation. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis. 2003;41(suppl 3):S1–91.

37.

National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(suppl 3):S1–201.

38.

National Kidney Foundation. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000;35(suppl 1):S1–140.

39.

National Kidney Foundation. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(suppl 3):S1–153.

40.

Locatelli F, Pisoni RL, Akizawa T, Cruz JM, DeOreo PB, Lameire NH, Held PJ. Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. Am J Kidney Dis. 2004;44(5 Suppl 2):27–33.PubMedCrossRef

41.

Port FK, Eknoyan G. The Dialysis Outcomes and Practice Patterns Study (DOPPS) and the Kidney Disease Outcomes Quality Initiative (K/DOQI): a cooperative initiative to improve outcomes for hemodialysis patients worldwide. Am J Kidney Dis. 2004;44(5 Suppl 2):1–6.PubMedCrossRef

42.

Combe C, McCullough KP, Asano Y, Ginsberg N, Maroni BJ,Pifer TB. Kidney Disease Outcomes Quality Initiative (K/DOQI) and the Dialysis Outcomes and Practice Patterns Study (DOPPS): nutrition guidelines, indicators, and practices. Am J Kidney Dis. 2004;44(5 Suppl 2):39–46.PubMedCrossRef

43.

Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT. Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Study Group. The Kidney Disease Outcomes Quality Initiative (K/DOQI) guideline for bone metabolism, disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis. 2005;46(5):925–32.PubMedCrossRef

44.

NFK. DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis. 2006;47:S17–85.CrossRef

45.

Tsukamoto Y. Future perspectives of guidelines for dialysis patients worldwide (in Japanese). Rinsho-toseki. 2006;22(7):59–70.

46.

Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334(1):13–8.PubMedCrossRef

47.

Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sower J for the National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Preservation of renal function in adults with hypertension and diabetes: a consensus approach. Am J Kidney Dis. 2000;36:646–61.PubMed

48.

Hosoya T, Toshima R, Ichida K, Tabe A, Sakai O. Changes in renal function with aging among Japanese. Intern Med. 1995;34(6):520–7.PubMedCrossRef

49.

Turnbull F, Blood Pressure Lowering Treatment Trialists’ Collaboration. Effect of different blood pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trial. Lancet. 2003;362:1527–35.PubMedCrossRef

50.

Nakai S, Shinzato T, Sanaka T, Kikuchi K, Kitaoka T, Shinoda T, Yamazaki C, Sakai R, Omori H, Morita O, Iseki K, Kubo K, Tabei K, Masakane I, Fushimi K, Wada A, Miwa N, Akiba T. The current state of chronic dialysis treatment in Japan (as of December 31, 2000). J Jpn Soc Dial Ther. 2002;35:1155–1184.

51.

Patient Registration Committee, Japanese Society for Dialysis Therapy, Tokyo, Japan. An overview of regular dialysis treatment in Japan as of 31 December 2003. Ther Aphr Dial. 2005;9(6):431–58.CrossRef

52.

Iseki K, Nakai S, Shinzato T, Morita O, Sinoda T, Kikuchi K, Wada A, Kimata N, Akiba T. Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan. Ther Apher Dial. 2007;11(3):183–8.PubMedCrossRef

53.

Mazzuci N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival. Kidney Int. 2000;58(5):2147–54.CrossRef

54.

Yamamoto T, Shimizu M, Morioka M, Kitano M, Wakabayashi W, Aizawa N. Role of angiotensin II in the pathogenesis of hyperdipsia in chronic renal failure. JAMA. 1986;256(5):601–3.CrossRef

55.

Oldenburg B, MacDonald GJ, Shelley S. Controlled trial of enarapril in patients with chronic fluid overload undergoing dialysis. Brit Med J. 1988;296:1089–91.CrossRef

56.

Kuriyama S, Tomonari H, Sakai O. Effect of cilazapril on hyperdipsia in hemodialyzed patients. Blood Purif. 1996;14:35–41.PubMed

57.

Kuriyama S, Otsuka Y, Iida R, Matsumoto K, Tokudome G, Hosoya T. Morning blood pressure predicts hypertensive organ damage in patients with renal diseases: effect of intensive antihypertensive therapy in patients with diabetic nephropathy. Intern Med. 2005;44(12):1239–46.PubMedCrossRef

Titel: Characteristics of the clinical practice patterns of hemodialysis in Japan in consideration of DOPPS and the NKF/DOQI guidelines
verfasst von: Satoru Kuriyama
Publikationsdatum: 01.06.2008
Verlag: Springer Japan
Erschienen in: Clinical and Experimental Nephrology / Ausgabe 3/2008
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI: https://doi.org/10.1007/s10157-007-0020-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Characteristics of the clinical practice patterns of hemodialysis in Japan in consideration of DOPPS and the NKF/DOQI guidelines

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2008

Relationship between antinuclear antibody and microalbuminuria in the general population: the Takahata study

Henoch–Schönlein purpura due to methicillin-sensitive Staphylococcus aureus bacteremia from central venous catheterization

NF-κB-dependent genes induced by proteinuria and identified using DNA microarrays

Severe hyponatremia and Schmidt’s syndrome

Efficacy and safety of Monascus purpureus Went rice in subjects with secondary hyperlipidemia

Dense deposit disease and the factor H H402 allele

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin